147
Views
19
CrossRef citations to date
0
Altmetric
Review

The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

, , , , , , & show all
Pages 191-205 | Published online: 17 Jan 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Gabriele Fragasso, Francesco Maranta, Claudia Montanaro, Anna Salerno, Camilla Torlasco & Alberto Margonato. (2012) Pathophysiologic therapeutic targets in hypertension: a cardiological point of view. Expert Opinion on Therapeutic Targets 16:2, pages 179-193.
Read now
Vassilios G. Athyros, Asterios Karagiannis, Emmanouel S. Ganotakis, Konstantinos Paletas, Vassilios Nicolaou, George Bacharoudis, Konstantinos Tziomalos, Theodore Alexandrides, Evangelos N. Liberopoulos & Dimitri P. Mikhailidis. (2011) Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Current Medical Research and Opinion 27:8, pages 1659-1668.
Read now
V. G. Athyros, A. Karagiannis, A. I. Hatzitolios, K. Paletas, C. Savopoulos, G. Giannoglou & D. P. Mikhailidis. (2009) Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study. Current Medical Research and Opinion 25:4, pages 971-980.
Read now
Keith Suckling. (2007) Drug discovery in the metabolic syndrome: context and some recent developments. Expert Opinion on Therapeutic Targets 11:6, pages 801-808.
Read now

Articles from other publishers (15)

Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Alexandros Sachinidis, Michalis Doumas & Vasilios Athyros. (2020) Hypertension in Metabolic Syndrome: Novel Insights. Current Hypertension Reviews 16:1, pages 12-18.
Crossref
Subhadeep Chakrabarti, Forough Jahandideh, Sandra T Davidge & Jianping Wu. (2018) Milk-Derived Tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) Enhance Insulin Sensitivity and Prevent Insulin Resistance in 3T3-F442A Preadipocytes. Journal of Agricultural and Food Chemistry 66:39, pages 10179-10187.
Crossref
Mona Schaalan, Waleed Mohamed & Rania Rahmo. (2016) Association of cardiac NT pro-β-type natriuretic peptide with metabolic and endothelial risk factors in young obese hypertensive patients: a perspective on the hypothalamic pituitary adrenal axis activation. Diabetology & Metabolic Syndrome 8:1.
Crossref
Marc J. Mathews, Edward H. Mathews & Leon Liebenberg. (2015) The mechanisms by which antidepressants may reduce coronary heart disease risk. BMC Cardiovascular Disorders 15:1.
Crossref
Subhadeep Chakrabarti & Jianping Wu. (2015) Milk-Derived Tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) Promote Adipocyte Differentiation and Inhibit Inflammation in 3T3-F442A Cells. PLOS ONE 10:2, pages e0117492.
Crossref
Vassilios G. Athyros, Moses S. Elisaf, Theodore Alexandrides, Apostolos Achimastos, Emmanouel Ganotakis, Eleni Bilianou, Asterios Karagiannis, Evangelos N. Liberopoulos, Konstantinos Tziomalos & Dimitri P. Mikhailidis. (2011) Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome. Angiology 63:5, pages 358-366.
Crossref
Kelly Putnam, Robin Shoemaker, Frederique Yiannikouris & Lisa A. Cassis. (2012) The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. American Journal of Physiology-Heart and Circulatory Physiology 302:6, pages H1219-H1230.
Crossref
Joel Handler. (2010) Managing Hypertensive Patients With Gout Who Take Thiazide. The Journal of Clinical Hypertension 12:9, pages 731-735.
Crossref
David SiegelM.D., M.P.M.D., M.P. & Arthur L.M. SwislockiM.D.M.D.. (2010) Hypertensive Treatment in Patients With Metabolic Syndrome. Metabolic Syndrome and Related Disorders 8:2, pages 95-104.
Crossref
Panagiotis Anagnostis, Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis & Dimitri P. Mikhailidis. (2009) The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis. The Journal of Clinical Endocrinology & Metabolism 94:8, pages 2692-2701.
Crossref
Yong-Qi LiHui JiYang ShenLi-Ju DingPei ZhuangYu-Lin YangQiu-Ju Huang. (2009) Chronic treatment with angiotensin AT 1 receptor antagonists reduced serum but not bone TGF-β 1 levels in ovariectomized rats . Canadian Journal of Physiology and Pharmacology 87:1, pages 51-55.
Crossref
Harry G. Preuss, Bobby Echard, Debasis Bagchi, Nicholas V. Perricone & Eiji Yamashita. (2009) Astaxanthin lowers blood pressure and lessens the activity of the renin-angiotensin system in Zucker Fatty Rats. Journal of Functional Foods 1:1, pages 13-22.
Crossref
Silvana Cianchetti, Alessandra Del Fiorentino, Renato Colognato, Rossella Di Stefano, Ferdinando Franzoni & Roberto Pedrinelli. (2008) Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 198:1, pages 22-28.
Crossref
Evangelos C. Rizos, Athanasia Spyrou, Evangelos N. Liberopoulos, Eleni C. Papavasiliou, Vasilis Saougos, Alexandros D. Tselepis & Moses Elisaf. (2007) Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential Hypertension. The Open Cardiovascular Medicine Journal 1:1, pages 22-26.
Crossref
David Siegel & Arthur L.M. Swislocki. (2007) Effects of Antihypertensives on Glucose Metabolism. Metabolic Syndrome and Related Disorders 5:3, pages 211-219.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.